H. Hilsden

Assessment of disease progression in dysferlinopathy

A. Pestronk, A. Blamire, J. Mendell, 2019, Neurology.

Assessment of disease progression in dysferlinopathy A 1-year cohort study

A. Pestronk, A. Blamire, J. Mendell, 2022 .

Three‐year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy

A. Blamire, A. Mayhew, K. Bushby, 2022, Journal of cachexia, sarcopenia and muscle.

Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials

H. Otero, A. Pestronk, A. Blamire, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach

A. Pestronk, A. Blamire, J. Mendell, 2022, Frontiers in Neurology.

Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI pattern

A. Pestronk, A. Blamire, J. Mendell, 2023, Neuromuscular Disorders.